Organization: Ontario Genomics Institute

Ontario Genomics drops “Institute” from its name

The Ontario Genomics Institute has dropped the “Institute” from its name to reflect the evolving nature of its work. After 15 years of operation, Ontario Genomics (OG) is now solidly industry facing, focused on identifying and securing sources of financing to assist in research translation and commercialization. In addition to securing federal provincial and other…

OGI-backed Cytognomix sells splicing pipeline

London ON-based Cytognomix has sold its Shannon Human Splicing Pipeline to the US National Cancer Institute (NCI). Cytognomix received early-stage support from the Ontario Genomics Institute through its Pre-commercialization Business Development Fund. The Shannon Pipeline is being used by the NCI to evaluate somatic and germline variants observed in tumor genome next-generation sequences for their…

TCAG receives $5.1 million in Genome Canada funding

The Centre for Applied Genomics (TCAG) has been awarded $5.1 million in Genome Canada’s Science and Technology Innovation Centre competition. The funding was made through the Ontario Genomics Institute (OGI) and is one of several awards made by Genome Canada, which is allowing recipient institutions to make their own announcements. The size of the competition…

Ontario-Quebec life science collaboration focus of meeting

Efforts to establish an Ontario-Quebec Life Sciences Corridor accelerated with a partnering event in which more than 80 participants participated in 130 individual meetings designed to foster collaboration between scientists and industry. The Toronto event was planned by the Ontario Genomics Institute, Genome Québec and the Quebec Consortium for Drug Discovery. Project pitches and one-to-one…

OGI launches public web site on genomics

The Ontario Genomics Institute (OGI) has launched a website designed to help give the general public a better understanding of genetics and genomics. The website — www.WhyGenomics.ca — will provide “bite-sized information” on how genomics plays a role in human health as well as crop and environmental protection. It will also offer details on OGI’s…

Ontario Genomics Institute launches affiliates program

The Ontario Genomics Institute (OGI) has launched an affiliates program to improve vendor-platform and user-platform access to leading-edge technologies. The affiliates program has six inaugural members based in Toronto, Ottawa, Guelph and London. The program seeks to overcome obstacles to researcher access to genomics technology platforms used for DNA sequencing, DNA arrays and protein mass…

Ontario Genomics Institute launches two new programs

The Ontario Genomics Institute (OGI) has launched two new programs designed to boost the participation of provincial genomics researchers in major international collaborations. The Genomics Technology Seeding program has already signed its first technology assessment agreement with The Hospital for Sick Children‘s Centre for Applied Genomics. If successful, the technology for generating specialized genotyping data…

Structural Genomics Consortium funding announced

Complete funding for the second phase of the Structural Genomics Consortium has been announced, with 13 partners (including three pharmaceutical firms) providing more than $105 million. The consortium — led by Dr Aled Edwards at the Univ of Toronto with three nodes in Toronto, the Univ of Oxford and the Karolinska Institutet — is dedicated…

Ontario funds RRI’s integration with UWO

The Ontario government is providing the Robarts Research Institute (RRI) with $23 million to facilitate its integration with the Univ of Western Ontario (UWO) and purchase new medical research equipment. RRI’s decision to formally merge with UWO coincides with the announced departure of Dr Mark Pozansky on April 30 to establish a consulting business. He…

Amorfix and OGI to develop Alzheimer’s blood test

Amorfix Life Sciences Inc is teaming with the Ontario Genomics Institute (OGI) to develop a blood test for Alzheimer’s disease. OGI will initially invest $100,000 to accelerate Amorfix’s EP-AD project, potentially followed by another $100,000 in two tranches in return for 50,000 in warrants convertible to shares….